NextCure, Simcere Zaiming Pharmaceutical Present Phase 1 Dose Escalation Data For SIM0505 At American Society For Clinical Oncology With Proprietary Topoisomerase 1 Inhibitor Payload

Loading news article.

NextCure, Simcere Zaiming Pharmaceutical Present Phase 1 Dose Escalation Data For SIM0505 At American Society For Clinical Oncology With Proprietary Topoisomerase 1 Inhibitor Payload | WAPE

NextCure, Simcere Zaiming Pharmaceutical Present Phase 1 Dose Escalation Data For SIM0505 At American Society For Clinical Oncology With Proprietary Topoisomerase 1 Inhibitor Payload

Article summary

Related companies

Comments —